Patients with locally advanced gastric cancers saw complete response rates of 18.3% from camrelizumab and rivoceranib plus ...

A recent report from MarketsAndMarkets projected that the global gastric cancer market accounted for USD 3.01 billion in 2023 and is expected to reach USD 18.43 billion by 2034 with a CAGR of 17.92% ...

Stephanie Thomas was diagnosed with terminal cancer after being removed from the patient list at her local GP after repeated ...

Platinum (cisplatin and oxaliplatin), taxanes (paclitaxel and docetaxel) and irinotecan are active agents used to treat gastric cancer. Based on the efficacy and tolerability of capecitabine ...

Stomach cancer is the second leading cause of cancer deaths globally Spicy, preserved foods, smoking, and alcohol elevate cancer risk Early detection through lifestyle changes and regular ...

Presentation will feature the ongoing Phase 2 study of agenT-797 in refractory gastric cancerNEW YORK, Dec. 18, 2024 (GLOBE ...

Cancer survival estimates in Europe highlight notable geographical and economic disparities. Several factors are driving gaps ...

Stomach cancer risk in men and women: Often referred to as a 'silent killer', stomach cancer or gastric cancer is a fatal disease. Its early symptoms are subtle and most patients usually dismiss ...

Pancreatic cancer is one of the most dangerous and deadly forms of cancer, claiming the lives of nearly 10,000 people each ...